These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17412645

  • 1. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P, Finn BC, Alvarez F, Bruetman JE, Trimarchi H.
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [Abstract] [Full Text] [Related]

  • 5. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M, Abramson RK.
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK, Iqbal FM, Singh B, Koneru J.
    Am J Ther; 2013 Dec; 20(5):569-71. PubMed ID: 21248614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T, Bøen A, Høymork SC.
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract] [Full Text] [Related]

  • 12. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF, Chen CY.
    Ren Fail; 2008 Jun; 30(8):822-4. PubMed ID: 18791959
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C, Marinaki S, Darema M, Skalioti C, Efthimiou A, Zavos G, Boletis JN.
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [Abstract] [Full Text] [Related]

  • 16. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H, Raman PG.
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract] [Full Text] [Related]

  • 17. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
    Nakazato Y, Ando S, Yamamoto T, Tamura N, Shimazu K.
    Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
    [Abstract] [Full Text] [Related]

  • 18. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK, Gazioğlu S.
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [Abstract] [Full Text] [Related]

  • 19. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M, Tang X, Wen S, Yue J, Wang H.
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [Abstract] [Full Text] [Related]

  • 20. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA.
    Gen Hosp Psychiatry; 2012 Jul; 34(3):290-8. PubMed ID: 22305367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.